SIMON HARFORD
Profile
First Name
: SIMON
Middle Name
:
Last Name
: HARFORD
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
N/A ACTIS GP LLP, N/A ACTIS LLP, N/A ACTIS NEW GP CO. LIMITED, N/A ACTIS NOMINEE LIMITED, RONALD BELL, JONATHON BOND, KNUT TORBJORN CAESAR, CHRISTOPHER COLES, N/A COPPER PARTNERS LLP, DANIEL PAUL FLETCHER, PATRICK LEDOUX, MENG ANN LIM, ALISTAIR MACKINTOSH, DAVID MORLEY, PETER SCHMID, MICHAEL TILL, JYOTINDRA MANIBHAI TRIVEDI, JOHN VAN WYK
EXECUTIVE OFFICER
N/A ACTIS GP LLP, N/A ACTIS LLP, N/A ACTIS NEW GP CO. LIMITED, N/A ACTIS NOMINEE LIMITED, RONALD BELL, JONATHON BOND, KNUT TORBJORN CAESAR, CHRISTOPHER COLES, N/A COPPER PARTNERS LLP, DANIEL PAUL FLETCHER, PATRICK LEDOUX, MENG ANN LIM, ALISTAIR MACKINTOSH, DAVID MORLEY, PETER SCHMID, MICHAEL TILL, JYOTINDRA MANIBHAI TRIVEDI, JOHN VAN WYK
EXECUTIVE OFFICER
WILLIAM D. BAIRD, III, SOL BARER, SOL J BARER, SOL J. BARER, ALEXANDER E BARKAS, JAMES BARRETT, LYNN D BLEIL, LYNN D. BLEIL, POL F BOUDES, POL F. BOUDES, BRADLEY CAMPBELL, BRADLEY L CAMPBELL, BRADLEY L. CAMPBELL, JEFFREY CASTELLI, JEFFREY P. CASTELLI, JEFFREY P. CASTELLI, PH.D., DAVID CLARK, DAVID M. CLARK, JOHN CROWLEY, JOHN F CROWLEY, JOHN F. CROWLEY, ENRIQUE DILONE, ROBERT ESSNER, JAYNE GERSKOWITZ, GEOFFREY P GILMORE, DONALD J HAYDEN, DONALD J. HAYDEN, JR., MICHAEL A KELLY, MICHAEL A. KELLY, JOHN R KIRK, JOHN R. KIRK, DAVID LOCKHART, DAVID J. LOCKHART, TED W. LOVE, MARGARET G MCGLYNN, MARGARET G. MCGLYNN, P SHERRILL NEFF, MATTHEW R PATTERSON, KENNETH W. PEIST, SAMANTHA PROUT, DAPHNE QUIMI, MICHAEL G RAAB, MICHAEL G. RAAB, EIRY L. ROBERTS, EIRY W ROBERTS, M.D., ELLEN S. ROSENBERG, GLEN SBLENDORIO, GLENN SBLENDORIO, GLENN P SBLENDORIO, GLENN P. SBLENDORIO, S NICOLE SCHAEFFER, JAMES N TOPPER, JAMES N. TOPPER, KEN VALENZANO, CRAIG A WHEELER, CRAIG A. WHEELER, BURKE W WHITMAN, BURKE W. WHITMAN, ROBERT WINKLER, JOAN C. WINTERBOTTOM
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-10-05
